Vasopressin Antagonists

*Prices reflect U.S. average retail price

Samsca (tolvaptan)

Tolvaptan (INN, trade names Samsca and Jinarc) is an aquaretic drug that functions as a selective, competitive vasopressin receptor 2 antagonist used to treat hyponatremia (low blood sodium levels) associated with congestive heart failure, cirrhosis, and the syndrome of inappropriate antidiuretic hormone (SIADH). Tolvaptan was approved by the U.S. Food and Drug Administration (FDA) on May 19, 2009, and is sold by Otsuka Pharmaceutical Co. under the trade name Samsca and in India is manufactured & sold by MSN laboratories Ltd. under the trade name Tolsama & Tolvat... Wikipedia

 

Manufacturer's Website: Samsca                                                                                                                  Average retail cost: *

 

* This drug is only available at select specialty pharmacies, which usually means it may be expensive.

Copyright  2006---2023  Automated Clinical Guidelines, LLC.  All rights reserved.